The Canadian Kennel Club Foundation
  • Home
  • About CKCF
    • Online Donation
    • Frequently Asked Questions
    • In-Kind Supporters
    • 2019 AGM
  • Grant Programs
    • Club Funding
    • Research Grants
    • Pawsitivity Grants
    • Projects
  • You Can Help!
    • Online Donation
  • Online Donation
  • Contact

Progress Report by University of Guelph's Ontario Veterinary College, Department of Pathobiology


microRNA analysis in dogs with lymphoma

Specific Project Objectives:
1)
Determine that the microRNA profile in newly diagnosed lymphoma bearing dogs is different from healthy dogs.
2) Determine what changes in the microRNA profile occur during standard therapy, and whether the changes correlate with response to therapy and length of remission

Objective 1

We have now determined microRNA profiles from blood samples from 23 healthy dogs, 17
dogs with T cell lymphoma (a subtype of lymphoma derived from T lymphocyte cells) and 44 dogs with B
cell lymphoma (a subtype of lymphoma derived from B lymphocyte cells. Using molecular biology
techniques specific for canine microRNAs, we discovered overexpression of 6 different microRNAs in
dogs with B cell lymphoma compared to healthy dogs, underexpression of 9 different microRNAs in dogs
with B cell lymphoma compared to healthy dogs, and underexpression of 3 different microRNAs in dogs
with T cell lymphoma. Furthermore, 14 microRNA were unique between tumour subtypes, and 2 in
common for each tumor (that could serve as general lymphoma markers). There were also 5 microRNA
present in normal healthy dogs that disappeared completely when lymphoma was present. Indeed, it
seems that a panel of specific microRNAs can be used to not only confirm the diagnosis but to
differentiate between the T and B cell subtypes. A poster and oral presentation have been presented at
an international scientific meeting (at which CKCF was acknowledged for funding), and there will be a
peer-reviewed manuscript published from this work soon (in which CKCF will be acknowledged). No
outstanding lab work remaining for this objective.​

Objective 2

For dogs with both T and B cell lymphoma, blood samples were assessed at weeks 0, 3, 6
and 25 during treatment for differences in expression of 40 different microRNAs. We observed several
changes over time and have developed a refined panel of approximately 10 specific microRNA that
correlate to successful response to therapy and length of remission period for B cell lymphoma
patients. It is less clear which microRNA might have a similar use for dogs with T cell lymphoma, since
we had fewer numbers of cases (T cell subtype accounts for only approximately one third of all
lymphoma cases) and the biological behavior of these tumours is more variable. Part of these results
have been presented at an international veterinary pathology meeting. Work remaining for this objective: We additionally wish to analyze additional samples in the period prior to relapse to determine if changes in expression of microRNA of interest start to change in blood samples before we can tell by physical examination that the dog’s cancer has returned. There are 9 dogs with each subtype of lymphoma for which we have samples in the 2-4 weeks preceding clinical relapse.
Picture

Make A Donation

By Phone: (877)887-CKCF (2523)
By Mail: The CKC Foundation, 200 Ronson Drive #402, Etobicoke, Ontario  M9W 5Z9
On-line: 
Picture
© 2014 Canadian Kennel Club Foundation.  All Rights reserved.
Contact Us

(c) Canadian Kennel Club Foundation 2014

No images on this site may be reproduced without written permission

The Canadian Kennel Club Foundation